Balance Sheet Data

Arcturus Therapeutics Holdings Inc. (ARCT)

$39.73

+0.97 (+2.50%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 36.7171.35462.89370.49391.8817,484.0286,206.53425,048.922,095,741.2610,333,237.57
Total Cash (%)
Account Receivables 4.482.182.123.372.76182.18898.274,429.0121,837.64107,672.44
Account Receivables (%)
Inventories ---000000.010.05
Inventories (%)
Accounts Payable 2.405.7910.7710.067.45489.062,411.3611,889.4358,621.88289,040.37
Accounts Payable (%)
Capital Expenditure -1.48-0.82-1.74-3.41-7.73-127.61-629.19-3,102.26-15,295.95-75,418.01
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.